MENU
Menu
MENU
Initial Results from the First of Its Kind Clinical Study Demonstrate cbdMD's Proprietary Broad Spectrum Hemp Extract Reduces Pain in Healthy Adults.
Charlotte, North Carolina–(Newsfile Corp. – November 17, 2022) – cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the first results from its recently concluded human clinical trial conducted at the University of South Carolina. These studies began in the fall of 2020 and the first results to be reported show the Company's proprietary broad spectrum hemp extract reduces pain in healthy adults. The ground breaking randomized, double blind, placebo controlled study was designed to explore the effects of cbdMD's proprietary broad spectrum cannabinoid blend on sleep, immunity, inflammation, mood, and pain in healthy adult subjects to further support the efficacy of the Company's products.
The Company and its subsidiary cbdMD Therapeutics, LLC will be releasing further results from the human clinical as they are finalized over the next few weeks and will eventually be publishing the results in a peer reviewed journal. The Company anticipates these favorable outcomes will form the basis for a number of future cbdMD product formulations. The study's results will also serve as preliminary data for additional future investigational studies executed by cbdMD's Therapeutics Division.
Study participants were given cbdMD's proprietary broad spectrum hemp extract blend containing 100 mg of CBD and other minor cannabinoids once per day for three months. The first results coming out of the study show that the perception and intensity of pain in healthy adults is significantly reduced with daily consumption of the Company's flagship broad spectrum blend. In anticipation of these results, the Company has recently launched a new flagship product in tincture, gummy and softgel which contains the clinically studied broad spectrum…
KISS PR Podcast Story Source link
This is the "wpengine" admin user that our staff uses to gain access to your admin area to provide support and troubleshooting. It can only be accessed by a button in our secure log that auto generates a password and dumps that password after the staff member has logged in. We have taken extreme measures to ensure that our own user is not going to be misused to harm any of our clients sites.
